<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00757640</url>
  </required_header>
  <id_info>
    <org_study_id>Firenze 1</org_study_id>
    <nct_id>NCT00757640</nct_id>
  </id_info>
  <brief_title>Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer Surgery</brief_title>
  <acronym>CHOLEGAS</acronym>
  <official_title>The CHOLEGAS Study: Multicentric Randomized, Double-blinded, Controlled Trial of Gastrectomy Plus Prophylactic Cholecystectomy Versus Gastrectomy Only, in Adults Submitted to Gastric Cancer Surgery With Curative Intent.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Italian Research Group for Gastric Cancer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria Careggi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Italian Research Group for Gastric Cancer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The patients will be divided into two groups: in the first group the patient will be&#xD;
      submitted to prophylactic cholecystectomy during standard surgery for curable gastric cancer&#xD;
      (subtotal or total gastrectomy), while in the second group will be submitted to standard&#xD;
      gastric surgery only.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of gallstones and gallbladder sludge is known to be higher in patients after&#xD;
      gastrectomy than in general population. This higher incidence is probably related to surgical&#xD;
      dissection of the vagus nerve branches and the anatomical gastrointestinal reconstruction.&#xD;
      Therefore, some surgeons perform routine concomitant cholecystectomy during standard surgery&#xD;
      for gastric malignancies. However, not all the patients who are diagnosed to have&#xD;
      cholelithiasis after gastric cancer surgery will develop symptoms or require additional&#xD;
      surgical treatments and a standard laparoscopic cholecystectomy is feasible even in those&#xD;
      patients who underwent previous gastric surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduced biliary complications</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved quality of life</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cholecystectomy</intervention_name>
    <description>prophylactic cholecystectomy during standard gastric surgery for cancer</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing standard gastric surgery for cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  gallbladder disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Farsi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chirurgia Generale e Oncologica Azienda Ospedaliero-Universitaria Careggi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Careggi - Chirurgia Generale ed Oncologica</name>
      <address>
        <city>Florence</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.gircg.it/</url>
    <description>official site of group study</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 20, 2008</study_first_submitted>
  <study_first_submitted_qc>September 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2008</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Italian Research Group for Gastric Cancer</investigator_affiliation>
    <investigator_full_name>Bencini Lapo</investigator_full_name>
    <investigator_title>Dr, PhD</investigator_title>
  </responsible_party>
  <keyword>gastric cancer, surgery, prophylactic cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

